Correct Answer: B. Insulin
Insulin is the only hormone among the options that employs receptor tyrosine kinase (RTK) signaling. Insulin binds to its cell-surface receptor, which is an intrinsic tyrosine kinase. Upon ligand binding, the receptor undergoes autophosphorylation at tyrosine residues in its intracellular domain, triggering a phosphorylation cascade involving insulin receptor substrates (IRS-1, IRS-2) and downstream kinases like PI3K and MAPK. This leads to glucose uptake (via GLUT4 translocation), glycogen synthesis, and lipogenesis. In the Indian clinical context, understanding insulin signaling is critical for managing type 2 diabetes mellitus, where impaired insulin receptor signaling (insulin resistance) is a central pathophysiology. The RTK mechanism is distinct from G-protein coupled receptors (GPCRs) and second-messenger systems used by other peptide hormones. This is a high-yield discriminator in endocrinology because RTK signaling produces rapid, direct phosphorylation cascades rather than slower second-messenger amplification.
Why the other options are wrong
A. TRH — TRH (thyrotropin-releasing hormone) is a tripeptide that binds to G-protein coupled receptors (GPCRs) on pituitary thyrotrophs, activating phospholipase C and the IP3/DAG second-messenger pathway. It does not use RTK signaling. This is a common trap because TRH is a peptide hormone, leading students to assume all peptide hormones share the same signaling mechanism. C. MSH — MSH (melanocyte-stimulating hormone) is a peptide hormone derived from POMC that signals via GPCR (melanocortin receptors), activating adenylyl cyclase and cAMP-dependent pathways. It does not activate tyrosine kinase cascades. Students may confuse it with growth factors, but MSH is a classic GPCR-mediated hormone. D. TSH — TSH (thyroid-stimulating hormone) is a glycoprotein hormone that binds to GPCR on thyroid follicular cells, activating the cAMP second-messenger system via Gs proteins. Despite being a protein hormone, TSH does not employ RTK signaling. The presence of multiple protein hormones in the options is an NBE trap to test whether students understand that signaling mechanism ≠ hormone type.
High-Yield Facts
- Insulin receptor is a transmembrane tyrosine kinase that autophosphorylates upon ligand binding and recruits IRS proteins for downstream signaling.
- RTK signaling produces rapid phosphorylation cascades (MAPK, PI3K pathways) leading to GLUT4 translocation and metabolic effects within minutes.
- TRH, TSH, and MSH all use GPCR-mediated signaling with second messengers (IP3/DAG or cAMP), not direct tyrosine kinase activation.
- Insulin resistance in type 2 diabetes involves impaired RTK signaling at the IRS-1/PI3K level, a key pathophysiology in Indian populations.
- Growth factors (EGF, PDGF, FGF) and insulin are the prototypical RTK ligands; peptide hormones predominantly use GPCRs.
Mnemonics
RTK Hormones: 'GIF' (Growth factors, Insulin, FGF) Remember RTK ligands as GIF: Growth factors (EGF, PDGF), Insulin, and FGF. All other classical peptide hormones (TRH, TSH, LH, FSH, MSH, ACTH) use GPCRs. Use this when you see a hormone list and need to spot the RTK outlier. GPCR Peptides: 'FLAT-M' (FSH, LH, ACTH, TSH, MSH) Most pituitary and peptide hormones use GPCR: FSH, LH, ACTH, TSH, MSH. Insulin is the exception among metabolic hormones. When you see insulin in a signaling question, think RTK immediately.
NBE Trap
NBE pairs multiple protein/peptide hormones (TRH, TSH, MSH, Insulin) to test whether students confuse hormone type (peptide vs. steroid) with signaling mechanism (RTK vs. GPCR). The trap is assuming all peptide hormones share the same receptor class.
Clinical Pearl
In Indian type 2 diabetes clinics, metformin and thiazolidinediones work by enhancing insulin receptor signaling and GLUT4 translocation—understanding RTK phosphorylation cascades explains why these drugs improve glucose uptake at the molecular level. Recognizing insulin's unique RTK mechanism is essential for comprehending insulin resistance, a hallmark of metabolic syndrome in Indian populations.
_Reference: Guyton & Hall Textbook of Medical Physiology, Ch. 79 (Insulin, Glucagon, and Diabetes Mellitus); Harrison's Principles of Internal Medicine, Ch. 397 (Diabetes Mellitus)_